NEW YORK (GenomeWeb News) – UK firm ProKyma today announced a £482,000 ($783,211) grant from the National Institute for Health Research to further develop its technology to detect circulating tumor cells.

The funding will be used by the spinout of the Defence Science and Technology Laboratory — a center of scientific excellence for the Ministry of Defence — to use its KymaSep technology to find a patient's specific cancer mutation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.